Table 5.
Radiographical Findings of Coronavirus Disease 2019 (COVID-19) Patients With Different Disease Severities at 3 and 12 Months Post-Discharge
| 3 m Post-Discharge | 12 m Post-Discharge | |||||||
|---|---|---|---|---|---|---|---|---|
| Total (n = 502) | Moderate (n = 63) | Severe (n = 378) | Critically Ill (n = 61) | Total (n = 486) | Moderate (n = 52) | Severe (n = 379) | Critically Ill (n = 55) | |
| Ground-glass opacity | 4 (0.8%) | 1 (1.6%) | 2 (0.5%) | 1 (1.6%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Patchy shadows | 92 (18.3%) | 16 (25.4%) | 69 (18.3%) | 7 (11.5%) | 50 (10.3%) | 2 (3.8%) | 37 (9.8%) | 11 (20.0%) |
| Fibrous stripes | 213 (42.4%) | 31 (49.2%) | 154 (40.7%) | 28 (45.9%) | 249 (51.2%) | 24 (46.2%) | 198 (52.2%) | 27 (49.1%) |
| Pleural thickening and adhesions | 188 (37.5%) | 21 (33.3%) | 139 (36.8%) | 28 (45.9%) | 62 (12.8%) | 6 (11.5%) | 49 (12.9%) | 7 (12.7%) |
| Enlarged and increased lymph nodes | 120 (23.9%) | 11 (17.5%) | 90 (23.8%) | 19 (31.1%) | 25 (5.1%) | 2 (3.8%) | 19 (5.0%) | 4 (7.3%) |
| Nodules | 73 (14.5%) | 12 (19.0%) | 55 (14.6%) | 6 (9.8%) | 180 (37.0%) | 21 (40.4%) | 143 (37.7%) | 16 (29.1%) |
| Calcification | 50 (10.0%) | 9 (14.3%) | 36 (9.5%) | 5 (8.2%) | 87 (17.9%) | 13 (25.0%) | 68 (17.9%) | 6 (10.9%) |
| Pleural effusion | 7 (1.4%) | 0 (0.0) | 6(1.6%) | 1 (1.6%) | 1 (0.2%) | 0 (0.0) | 1 (0.3%) | 0 (0.0) |
| Pericardial effusion | 11 (2.2%) | 1 (1.6%) | 9 (2.4%) | 1 (1.6%) | 1 (0.2%) | 0 (0.0) | 1 (0.3%) | 0 (0.0) |
| Pulmonary bullae | 23 (4.6%) | 7 (11.1%) | 12 (3.2%) | 4 (6.6%) | 17 (3.5%) | 2 (3.8%) | 12 (3.2%) | 3 (5.5%) |
| Emphysema | 51 (10.2%) | 8 (12.7%) | 35 (9.3%) | 8 (13.1%) | 78 (16.0%) | 11 (21.2%) | 58 (15.3%) | 9 (16.4%) |
| Bronchiectasis | 21 (4.2%) | 3 (4.8%) | 14 (3.7%) | 4 (6.6%) | 22 (4.5%) | 1 (1.9%) | 18 (4.7%) | 3 (5.5%) |
| Local thickening of the pericardium | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (0.6%) | 0 (0.0) | 3 (0.8%) | 0 (0.0) |
Values are n (%), unless stated otherwise.